Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach

This publication has 11 references indexed in Scilit:

• Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach
  Bioorganic & Medicinal Chemistry Letters, 2001
• Protein kinase inhibitors: emerging pharmacophores 1997 - 2000
  Expert Opinion on Therapeutic Patents, 2001
• p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas
  Bioorganic & Medicinal Chemistry Letters, 2000
• Discovery of a new class of p38 kinase inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2000
• 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2000
• Raf kinase inhibitors
  Expert Opinion on Therapeutic Patents, 1998
• The Role of Raf Kinases in Development and Growth of Tumors
  Published by Springer Nature ,1997
• Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
  Nature Medicine, 1996
• Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro.
  Molecular and Cellular Biology, 1993
• FUNCTION AND REGULATION OF RAS
  Annual Review of Biochemistry, 1993